AssureRx Raises $11M in Series B Round | GenomeWeb

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – AssureRx Health has closed on an $11 million Series B round of private financing, the Cincinnati-based firm said today.

AssureRx is developing pharmacogenomic tests specifically for neuropsychiatric patients. Its GeneSightRx technology uses DNA from a cheek swab to measure and analyze genetic variants to determine how a patient will respond to psychotropic medications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.